← Back to catalog
👩‍⚕️ Healthcare

CMO Dr. Maya

Clinical Authority
Chief Medical Officer who serves as the ultimate clinical gatekeeper for health tech adoption. Evaluates every vendor through patient safety and regulatory compliance first, ROI second.
Patient safety advocateClinical gatekeeperRegulatory expertPhysician champion
Download JSON AI-ready structured data
Individual Persona
$29
One-time purchase. Instant access.
Buy This Persona Get Healthcare Pack — $99
  • Full buyer brief (all sections below)
  • Demographics & psychographics
  • Buying triggers & objections
  • Channel preferences & timeline
  • Messaging tips for sales teams
6-18 months
Deal Cycle
Medical conferences / Peer referrals
Channel
Regulatory burden + clinician burnout
Pain Point
Evidence-based, safety-first
Decision Style
👤

Demographics

Title Chief Medical Officer / VP of Medical Affairs
Location Major US metro areas with large health systems
Age Range 45-60
Education MD or DO, often with MBA or MPH
Reports To CEO / Board of Directors
Company Size 500-10,000+ employees
Income Range $350K-$600K total comp
Industry Segment Health systems, hospital networks, large medical groups
🧠

Psychographics

Values
Patient safety above allEvidence-based medicineClinical workflow integrityClinician wellbeing
Motivations
  • Reducing medical errors and adverse events
  • Alleviating clinician burnout from administrative burden
  • Staying ahead of CMS and Joint Commission requirements
  • Positioning the health system as a clinical innovation leader
Frustrations
  • Vendors who lead with technology instead of clinical outcomes
  • Solutions that increase documentation burden on physicians
  • Poor interoperability with existing EHR systems
  • Lack of peer-reviewed evidence for health tech efficacy
Personality Type

Methodical and evidence-driven. Demands clinical validation before any demo. Distrusts marketing claims without supporting literature.

🎯

Buying Triggers

  • Joint Commission or CMS audit findings requiring remediation
  • Clinician burnout survey scores dropping below acceptable threshold
  • Patient safety incident that surfaces a preventable gap
  • New strategic plan with digital health transformation mandate
  • Competitor health system deploys technology generating positive press
🛑

Common Objections

  • Show me the clinical evidence — what peer-reviewed studies support this?
  • How does this affect physician workflow and EHR documentation time?
  • We need FDA clearance documentation before we can even evaluate this
  • Our CMIO and informatics team must validate the clinical logic
  • We have had bad experiences with vendors who overpromised clinical outcomes
📡

Channels & Media

social
LinkedIn (thought leadership)MGMA and AMA member forums
content
Peer-reviewed case studiesClinical outcome whitepapersPilot program results with outcome data
research
Clinical literature (PubMed)KLAS Research ratingsAdvisory Board and Gartner health reports
preferred
HIMSS conferencesNEJM and JAMA publicationsPeer CMO referrals
⏱️

Timeline & Cycle

Renewal Cycle 3-5 year contracts typical
Total Deal Cycle 6-18 months
Best Time To Reach Q4 budget planning, post-accreditation cycles, or after adverse event disclosures
Evaluation To Decision 6-12 months
Awareness To Evaluation 2-6 months
💡

Messaging Tips

  • Lead with patient outcomes data — never with technology features
  • Reference FDA clearance and clinical validation prominently in all materials
  • Include clinician time-savings metrics alongside safety metrics
  • Provide a clinical evidence dossier as a leave-behind
  • Avoid AI-powered without specifics on the training data and validation methodology

🔒 Purchase to unlock the full buyer brief

Unlock for $29